Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial-Reference-Cited by-同舟云学术

Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial

Published:2008-04 Issue:7 Volume:121 Page:615-619
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:Chinese Medical Journal

Author:

LÜ Liang-jing,TENG Jia-lin,BAO Chun-de,HAN Xing-hai,SUN Ling-yun,XU Jiang-hua,LI Xing-fu,WU Hua-xiang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference12 articles.

1. Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells

2. Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice

3. Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The SMILE study: Study of long-term methotrexate and iguratimod combination therapy in early rheumatoid arthritis;Chinese Medical Journal;2024-07-26

2. Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials;Frontiers in Pharmacology;2023-12-07

3. Monotreatment With Conventional Antirheumatic Drugs or Glucocorticoids in Rheumatoid Arthritis;JAMA Network Open;2023-10-06

4. Effects of iguratimod in the treatment of palindromic rheumatism: Case report;Int. Journal of Clinical Pharmacology and Therapeutics;2023-09-01

5. Iguratimod efficacy in palindromic rheumatism treatment;Immunity, Inflammation and Disease;2023-06